La Jolla, CA, United States of America

Gary A Morris

USPTO Granted Patents = 32 

 

 

Average Co-Inventor Count = 12.8

ph-index = 7

Forward Citations = 148(Granted Patents)


Location History:

  • La Jolla, CA (US) (2018 - 2024)
  • San Diego, CA (US) (2021 - 2024)
  • San Marcos, CA (US) (2023 - 2024)
  • Gilbert, AZ (US) (2024)

Company Filing History:


Years Active: 2018-2025

Loading Chart...
Loading Chart...
Loading Chart...
32 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Gary A. Morris in Diabetes Care

Introduction

Gary A. Morris is a prominent innovator based in La Jolla, California, known for his significant contributions to the field of diabetes care. With an impressive portfolio of 30 patents, Morris has pioneered several groundbreaking technologies that enhance the management of glucose levels for individuals living with diabetes. His work has led to advancements that not only provide users with critical health insights but also improve their overall quality of life.

Latest Patents

Morris's latest patents showcase his focus on developing personalized solutions for diabetes management. One such invention is a "System and method for providing alerts optimized for a user." This innovative system is designed to deliver smart alerts to users, specifically concerning their diabetic conditions. By predicting whether a user is cognitively aware of their current state, the system ensures that alerts are meaningful and timely, effectively personalizing the user experience. Another noteworthy patent is for "Systems and methods for distributing continuous glucose data," which pertains to the secure transmission and management of glucose data acquired by medical devices. This invention facilitates monitoring glucose levels and synchronizing health data across various applications, enhancing accessibility while maintaining data security.

Career Highlights

Gary A. Morris currently works with Dexcom, Inc., a leading company in continuous glucose monitoring technology. His role at Dexcom has positioned him at the forefront of innovation in diabetes care, allowing him to leverage his expertise in developing technologies that make a significant impact on patients' lives. He has maintained a trajectory of excellence throughout his career, consistently contributing to advancements that address critical health issues faced by diabetics.

Collaborations

Throughout his career, Morris has collaborated with esteemed colleagues such as Apurv Ullas Kamath and Katherine Yerre Koehler. Together, they have fostered a collaborative environment that emphasizes creativity and innovation, leading to the development of highly effective health management technologies.

Conclusion

Gary A. Morris is a vital figure in the medical technology field, particularly in diabetes management. His innovative patents and collaborative efforts reflect a deep commitment to improving healthcare outcomes for individuals with diabetes. As he continues to push the boundaries of technology in this sector, his contributions are set to leave a lasting legacy in the realm of health innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…